The DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice
Abstract
Myostatin (MSTN) is a secreted growth inhibitor expressed in muscle and adipose. We sought to determine whether expression of MSTN, its receptor activin RIIb (ActRIIb), or its binding protein follistatin-like-3 (FSTL3) are altered in subcutaneous or visceral adipose or in skeletal muscle in response to obesity. MSTN and ActRIIb mRNA levels were low in subcutaneous (SQF) and visceral fat (VF) from wild-type mice but were 50- to 100-fold higher in both SQF and VF from ob/ob compared with wild-type mice. FSTL3 mRNA levels were increased in SQF but decreased in VF in ob/ob compared with wild-type mice. Moreover, MSTN mRNA levels were twofold greater in tibialis anterior (TA) from ob/ob mice, whereas ActRIIb and FSTL3 mRNA levels were unchanged. MSTN mRNA levels were also increased in TA and SQF from mice on a high-fat diet. Injection of ob/ob mice with recombinant leptin caused FSTL3 mRNA levels to decrease in both VF and SQF in ob/ob mice; MSTN and ActRIIb mRNA levels tended to decrease only in VF. Finally, MSTN mRNA levels and promoter activity were low in adipogenic 3T3-L1 cells, but an MSTN promoter-reporter construct was activated in 3T3-L1 cells by cotransfection with the adipogenic transcription factors SREBP-1c, C/EBPalpha, and PPARgamma. These results demonstrate that expression of MSTN and its associated binding proteins can be modulated in adipose tissue and skeletal muscle by chronic obesity and suggest that alterations in their expression may contribute to the changes in growth and metabolism of lean and fat tissues occurring during obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“so both circulating and SkM myostatin levels are present in obese subjects when compared to non-obese subjects (Allen et al., 2008; Hittel et al., 2009).”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Allen et al., 2008
In the citing paper
“Myostatin mRNA levels increase substantially in genetically-modified obese mice (leptin-deficient ob/ob mice) and also in those receiving a high fat diet (HFD)”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Allen et al., 2008
Citations
Cites
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Chen, D., Zhao, M., & Mundy, G. R. (2004) · Growth Factors · doi:10.1080/08977190412331279890 · Cited by 1,921
Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. S., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,619
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Induction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P. A., Esquela‐Kerscher, A., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S. (2002) · Science · doi:10.1126/science.1069525 · Cited by 908
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal‐Puig, A., Jimenez‐Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B. M., Flier, J. S., & Moller, D. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118703 · Cited by 660
Cited by
Sorted by citations
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Pedersen, B. K. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120033 · Cited by 516
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402
Leal, L. G., Lopes, M. A., & Batista, M. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01307 · Cited by 382
“Myostatin mRNA levels increase substantially in genetically-modified obese mice (leptin-deficient ob/ob mice) and also in those receiving a high fat diet (HFD), so both circulating and SkMmyostatin levels are present in obese subjects when compared to non-obese subjects (Allen et al., 2008; Hittel et al., 2009).”
BackgroundBone and muscle: Interactions beyond mechanical
Brotto, M. A. P., & Bonewald, L. F. (2015) · Bone · doi:10.1016/j.bone.2015.02.010 · Cited by 360
The role of myostatin in muscle wasting: an overview
Elkina, Y., von Haehling, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0035-5 · Cited by 371
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
Myokines and Adipokines: Involvement in the Crosstalk between Skeletal Muscle and Adipose Tissue
Li, F., Li, Y., Duan, Y., Hu, C.-A. A., Tang, Y., & Yin, Y. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.003 · Cited by 288
Myostatin decreases with aerobic exercise and associates with insulin resistance
HITTEL, D. S., AXELSON, M., SARNA, N., SHEARER, J., HUFFMAN, K. M., & KRAUS, W. E. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0b9a8 · Cited by 271
Myostatin Directly Regulates Skeletal Muscle Fibrosis
Li, Z. B., Kollias, H. D., & Wagner, K. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802585200 · Cited by 267
The effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.109.882068 · Cited by 238
The effects of obesity on skeletal muscle contractile function
Tallis, J. A., James, R. S., & Seebacher, F. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.163840 · Cited by 235
Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines
Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210
Expression and function of myostatin in obesity, diabetes, and exercise adaptation
ALLEN, D. L., HITTEL, D. S., & MCPHERRON, A. C. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182178bb4 · Cited by 207
Self-citationZamani, N., & Brown, C. (2010) · Endocrine Reviews · doi:10.1210/er.2010-0018 · Cited by 214
Activin signaling as an emerging target for therapeutic interventions
Tsuchida, K., Nakatani, M., Hitachi, K., Uezumi, A., Sunada, Y., Ageta, H., & Inokuchi, K. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-15 · Cited by 202
Qian, L., Tang, M., Yang, J., Wang, Q., Cai, C., Jiang, S., Li, H., Jiang, K., Gao, P., Ma, D., et al. (2015) · Scientific Reports · doi:10.1038/srep14435 · Cited by 196
Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188
Inhibin at 90: From Discovery to Clinical Application, a Historical Review
Makanji, Y., Zhu, J., Mishra, R. K., Holmquist, C., Wong, W. P. S., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1003 · Cited by 187
Muscle‐bone crosstalk and potential therapies for sarco‐osteoporosis
Li, G., Zhang, L., Wang, D., AIQudsy, L., Jiang, J. X., Xu, H., & Shang, P. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28946 · Cited by 166
Hamrick, M. W., Herberg, S., Arounleut, P., He, H.-Z., Shiver, A. L., Qi, R.-Q., Zhou, L., Isales, C. M., & Mi, Q. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.079 · Cited by 157
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
Akpan, I., Goncalves, M. D., Dhir, R., Yin, X., Pistilli, E. E., Bogdanovich, S., Khurana, T. S., Ucran, J., Lachey, J., & Ahima, R. S. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.162 · Cited by 140
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Baig, M. H., Ahmad, K., Moon, J. S., Park, S.-Y., Ho Lim, J., Chun, H. J., Qadri, A. F., Hwang, Y. C., Jan, A. T., Ahmad, S. S., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.876078 · Cited by 135
Sáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez-Ambrosi, J., & Frühbeck, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006808 · Cited by 135
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger‐Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 139
Mechanisms by Which Skeletal Muscle Myokines Ameliorate Insulin Resistance
Balakrishnan, R., & Thurmond, D. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094636 · Cited by 143
Myostatin: more than just a regulator of muscle mass
Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.02.001 · Cited by 125
Metabolic Functions of Myostatin and GDF11
McPherron, A. C. (2010) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152210793663810 · Cited by 128
Maurel, D. B., Jähn, K., & Lara-Castillo, N. (2017) · Biomedicines · doi:10.3390/biomedicines5040062 · Cited by 127
Sharma, M., McFarlane, C., Kambadur, R., Kukreti, H., Bonala, S., & Srinivasan, S. (2015) · IUBMB Life · doi:10.1002/iub.1392 · Cited by 120
Endocrine Crosstalk Between Muscle and Bone
Brotto, M. A. P., & Johnson, M. L. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0209-0 · Cited by 120
Allen, D. L., & Loh, A. S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00142.2010 · Cited by 119
Family-Based Analysis of Candidate Genes for Polycystic Ovary Syndrome
Ewens, K. G., Stewart, D. R., Ankener, W., Urbanek, M., McAllister, J. M., Chen, C., Baig, K. M., Parker, S. C. J., Margulies, E. H., Legro, R. S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2703 · Cited by 110
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13359 · Cited by 112
A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling
Koncarevic, A., Kajimura, S., Cornwall-Brady, M. R., Andreucci, A., Pullen, A. E., Sako, D., Kumar, R., Grinberg, A. V., Liharska, K., Ucran, J. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1016 · Cited by 111
Role of microRNAs in skeletal muscle hypertrophy
Hitachi, K., & Tsuchida, K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2013.00408 · Cited by 106
Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
Brandt, C., Nielsen, A. R., Fischer, C. P., Hansen, J. B., Pedersen, B. K., & Plomgaard, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037236 · Cited by 103
New insights into the mechanisms of activin action and inhibition
Walton, K. L., Makanji, Y., & Harrison, C. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.030 · Cited by 100
Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans
Amor, M., Itariu, B. K., Moreno-Viedma, V., Keindl, M., Jürets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M., & Stulnig, T. M. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0641-5546 · Cited by 93
BMPs and their clinical potentials
Kim, M.-J., & Choe, S. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.10.619 · Cited by 97
Subdiaphragmatic vagal afferent nerves modulate visceral pain
Chen, S., Wu, X.-Y., Cao, Z. J., Fan, J., Wang, M., Owyang, C., & Li, Y. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00588.2007 · Cited by 89
Metabolism and the heart: An overview of muscle, fat, and bone metabolism in heart failure
Loncar, G., Fülster, S., von Haehling, S., & POPOVIC, V. M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.079 · Cited by 85
Hjorth, M., Pourteymour, S., Görgens, S. W., Langleite, T. M., Lee, S., Holen, T., Gulseth, H. L., Birkeland, K. I., Jensen, J., Drevon, C. A., et al. (2016) · Acta Physiologica · doi:10.1111/apha.12631 · Cited by 83
Bagheri, R., Moghadam, B. H., Church, D. D., Tinsley, G. M., Eskandari, M., Moghadam, B. H., Motevalli, M. S., Baker, J. S., Robergs, R. A., & Wong, A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110869 · Cited by 81
Myostatin – The Holy Grail for Muscle, Bone, and Fat?
Buehring, B., & Binkley, N. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0160-5 · Cited by 79
Mastrocola, R., Collino, M., Nigro, D., Chiazza, F., D’Antona, G., Aragno, M., & Minetto, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119587 · Cited by 77
Sheng, R., Cao, M., Song, M., Wang, M., Zhang, Y., Shi, L., Xie, T., Li, Y., Wang, J., & Rui, Y. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.09.007 · Cited by 85
Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy
Guo, T., Bond, N. D., Jou, W., Gavrilova, O., Portas, J., & McPherron, A. C. (2012) · Diabetes · doi:10.2337/db11-0915 · Cited by 68
Wetzlich, B., Nyakundi, B. B., & Yang, J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05120-y · Cited by 74
Lee, S.-J., Lehar, A., Liu, Y., Ly, C. H., Pham, Q.-M., Michaud, M., Rydzik, R., Youngstrom, D. W., Shen, M. M., Kaartinen, V., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019263117 · Cited by 59
Myokines as possible therapeutic targets in cancer cachexia
Manole, E., Ceafalan, L. C., Popescu, B. O., Dumitru, C., & Bastian, A. E. (2018) · Journal of Immunology Research · doi:10.1155/2018/8260742 · Cited by 60
Allen, D. L., Cleary, A. S., Lindsay, S. F., Loh, A. S., & Reed, J. M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00504.2010 · Cited by 61
Liu, X., Bauman, W. A., & Cardozo, C. P. (2018) · Physiological Reports · doi:10.14814/phy2.13837 · Cited by 61
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58
Myostatin — From the Mighty Mouse to cardiovascular disease and cachexia
Dschietzig, T. B. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.021 · Cited by 55
Cleasby, M. E., Jarmin, S., Eilers, W., Elashry, M. I., Andersen, D. K., Dickson, G., & Foster, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2013 · Cited by 57
Activins in adipogenesis and obesity
Dani, C. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.28 · Cited by 64
Allen, D. L., McCall, G. E., Loh, A. S., Madden, M. C., & Mehan, R. S. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00296.2010 · Cited by 55
Qi, H., Ren, J., Ba, L., Song, C., Zhang, Q., Cao, Y., Shi, P., Fu, B., Liu, Y., & Sun, H. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.003 · Cited by 54
Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation
Grade, C. V. C., Mantovani, C. S., & Alvares, L. E. (2019) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0338-5 · Cited by 54
Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects
Watts, R., McAinch, A. J., Dixon, J. B., O’Brien, P. E., & Cameron‐Smith, D. (2013) · Obesity · doi:10.1002/oby.20070 · Cited by 52
Arounleut, P., Bowser, M., Upadhyay, S. K., Shi, X., Fulzele, S., Johnson, M. H., Stranahan, A. M., Hill, W., Isales, C. M., & Hamrick, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072330 · Cited by 49
Cai, C., Qian, L., Jiang, S., Sun, Y., Wang, Q., Ma, D., Xiao, G., Li, B., Xie, S., Gao, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16822 · Cited by 51
Physical activity and its mechanistic effects on prostate cancer
Wekesa, A., Harrison, M., & Watson, R. W. G. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.9 · Cited by 47
Bonala, S., Lokireddy, S., McFarlane, C., Patnam, S., Sharma, M., & Kambadur, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529925 · Cited by 48
RetractedAllen, D. L., Cleary, A. S., Hanson, A. M., Lindsay, S. F., & Reed, J. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2010 · Cited by 46
Chen, M., Han, D., Yang, J., Yang, Y., Ho, H., & Yang, W. (2012) · Human Reproduction · doi:10.1093/humrep/des209 · Cited by 44
Chang, H., Pan, H.-H., Cheng, J., Zhu, Y., & Leung, P. C. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.009 · Cited by 44
Sanchis‐Gomar, F., López‐López, S., Morales, C. R., Maffulli, N., Lippi, G., & Pareja-Galeano, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01463 · Cited by 45
Follistatin-Like Proteins: Structure, Functions and Biomedical Importance
Parfenova, O. K., Kukes, V. G., & Grishin, D. V. (2021) · Biomedicines · doi:10.3390/biomedicines9080999 · Cited by 44
Increased glial glutamate transporter EAAT2 expression reduces visceral nociceptive response in mice
Lin, Y., Tian, G., Roman, K., Handy, C. R., Travers, J. B., Lin, C.-L. G., & Stephens, R. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90556.2008 · Cited by 40
Allen, D. L., Uyenishi, J. J., Cleary, A. S., Mehan, R. S., Lindsay, S. F., & Reed, J. M. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00325.2009 · Cited by 40
Increased circulating myostatin in patients with type 2 diabetes mellitus
Wang, F., Liao, Y., Li, X., Ren, C., Cheng, C., & Ren, Y. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0092-9 · Cited by 39
Wilhelmsen, A., Tsintzas, K., & Jones, S. W. (2021) · GeroScience · doi:10.1007/s11357-021-00322-4 · Cited by 42
Roseno, S. L., Davis, P. R., Bollinger, L. M., Powell, J. J. S., Witczak, C. A., & Brault, J. J. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0037-y · Cited by 36
Bolton, J. L., Montastier, É., Carayol, J., Bonnel, S., Mir, L., Marqués, M.-A., Astrup, A. V., Saris, W. H. M., Iacovoni, J. S., Vialaneix, N., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3997 · Cited by 38
Buscemi, C., Ferro, Y., Pujia, R., Mazza, E., Boragina, G., Sciacqua, A., Piro, S., Pujia, A., Sesti, G., Buscemi, S., et al. (2021) · Nutrients · doi:10.3390/nu13061909 · Cited by 38
Masticatory muscle function affects the pathological conditions of dentofacial deformities
Yamada, T., Sugiyama, G., & Mori, Y. (2020) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2019.12.001 · Cited by 39
Myostatin: a potential therapeutic target for metabolic syndrome
Yang, M., Liu, C., Jiang, N., Liu, Y., Luo, S., Li, C., Zhao, H., Han, Y., Chen, W., Li, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1181913 · Cited by 33
Zarfeshani, A., Ngo, S., & Sheppard, A. M. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-27 · Cited by 32
Kazemi, F. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0373-9 · Cited by 33
Decreasing Lean Body Mass with Age: Challenges and Opportunities for Novel Therapies
Boutari, C., & Mantzoros, C. S. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.4.422 · Cited by 34
Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis
Li, N., Yang, Q., Walker, R. G., Thompson, T. B., Du, ., & Rodgers, B. D. (2015) · Endocrinology · doi:10.1210/en.2015-1546 · Cited by 29
Dieli-Conwright, C. M., Spektor, T. M., Rice, J. C., Sattler, F. R., & Schroeder, E. T. (2012) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e318251083f · Cited by 29
Can Exercise Training Alter Human Skeletal Muscle DNA Methylation?
Garcia, L. A., Bustos, R. Z., Day, S. E., Campos, B., Hamzaoui, Y., Wu, L., Leon, A. D., Krentzel, J., Coletta, R. L., Filippis, E. D., et al. (2022) · Metabolites · doi:10.3390/metabo12030222 · Cited by 28
Founds, S. A., Ren, D., Roberts, J. M., Jeyabalan, A., & Powers, R. W. (2014) · Reproductive Sciences · doi:10.1177/1933719114529372 · Cited by 27
Eilers, W., Chambers, D. J., Cleasby, M. E., & Foster, K. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00185.2019 · Cited by 29
Retraction: Pid1 Induces Insulin Resistance in Both Human and Mouse Skeletal Muscle during Obesity
Bonala, S., McFarlane, C., Ang, J., Lim, R., Lee, M., Chua, H., Lokireddy, S., Patnam, S., Leow, M. K., Meng, K. C., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1048 · Cited by 26
RetractedFighting obesity: When muscle meets fat
Yang, X., Bi, P., & Kuang, S. (2014) · Adipocyte · doi:10.4161/21623945.2014.964075 · Cited by 25
Leptin signaling in skeletal muscle after bed rest in healthy humans
Guerra, B., Ponce‐González, J. G., Morales‐Álamo, D., Guadalupe‐Grau, A., Kiilerich, K., Fuentes, T., Ringholm, S., Biensø, R. S., Santana, A., Lundby, C., et al. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2779-4 · Cited by 25
Liu, K., Zhang, X., Wei, W., Liu, X., Tian, Y., Han, H., Zhang, L., Wu, W., & Chen, J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00405.2018 · Cited by 25
Crosstalk between bone and other organs
Yuan, W., & Song, C. (2022) · Medical Review · doi:10.1515/mr-2022-0018 · Cited by 27
Guo, W., Wong, S., & Bhasin, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071017 · Cited by 24
Expression of myostatin, myostatin receptors and follistatin in diabetic rats submitted to exercise
Dibai, D. B., Bueno, P. G., Silva, R. N., Nakahara, N. H., Selistre-de-Araújo, H. S., Nonaka, K. O., & Leal, A. M. O. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05690.x · Cited by 24
Legaard, G. E., & Pedersen, B. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814593-7.00013-x · Cited by 24
Obesity and Low-Grade Inflammation Increase Plasma Follistatin-Like 3 in Humans
Brandt, C., Pedersen, M., Rinnov, A., Andreasen, A. S., Møller, K., Højman, P., Pedersen, B. K., & Plomgaard, P. (2014) · Mediators of Inflammation · doi:10.1155/2014/364209 · Cited by 22
Yoo, A., Ahn, J., Kim, M. J., Seo, H., Hahm, J., Jung, C. H., & Ha, T. Y. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111439 · Cited by 22
Perry, C. A., Van Guilder, G. P., & Butterick, T. A. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00516-9 · Cited by 16
Metadata
- Authors
- Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S.
- Affiliations
- University of Colorado Boulder (US)
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2008-05
- Volume
- 294
- Issue
- 5
- Pages
- E918-E927
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1986156265
- Cited by
- 183
- References
- 50
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 11 · 2021: 11 · 2020: 8 · 2019: 10 · 2018: 9 · 2017: 8 · 2016: 8 · 2015: 17 · 2014: 18 · 2013: 17 · 2012: 14
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01 AR-0505-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- myostatin, FSTL3, obesity, adipose tissue, skeletal muscle, subcutaneous adipose tissue, visceral fat, ob/ob mice, leptin, high-fat diet, adipogenic transcription factors, SREBP-1c, C/EBPα, PPARγ, 3T3-L1 cells, gene expression regulation
- MeSH terms
- Adipose Tissue, Animals, Cells, Cultured, Cloning, Molecular, Diet, Dietary Fats, DNA, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, Proteins, RNA, Messenger, Transfection, Signal Transduction, Transforming Growth Factor beta, 3T3 Cells, Muscle, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Leptin, Activin Receptors, Type II, Follistatin-Related Proteins, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review